Results 11 to 20 of about 522,479 (352)
Nebulized heparin in burn patients with inhalation trauma : safety and feasibility [PDF]
, 2020 Background: Pulmonary hypercoagulopathy is intrinsic to inhalation trauma. Nebulized heparin could theoretically be beneficial in patients with inhalation injury, but current data are conflicting.
Binnekade, Jan M. +17 more
core +2 more sources
Blended Heparin: A new Perspective to Guarantee the Supply of a Life-Saving Drug?
Clinical and Applied Thrombosis/Hemostasis, 2023 The risk of heparin shortage opens up the possibility of diversifying the sources of heparin by introducing products of other animal/organ origins. In addition to bovine heparin, already used in the past in the United States and Europe, ovine heparin can
Marco Guerrini MS
doaj +1 more source
Heparin-induced thrombocytopenia: a rare presentation with skin necrosis
Dermatology Reports, 2023 Heparin-induced thrombocytopenia is the most clinically relevant non-haemorrhagic complication of heparin and is characterised by the presence of anti-PF4/heparin-IgG antibodies.
Filipa David +3 more
doaj +1 more source
pH-Sensitive Chitosan–Heparin Nanoparticles for Effective Delivery of Genetic Drugs into Epithelial Cells [PDF]
, 2019 Chitosan has been extensively studied as a genetic drug delivery platform. However, its efficiency is limited by the strength of DNA and RNA binding.
Korzhikov-Vlakh, Viktor +7 more
core +1 more source
Gynecology Obstetrics & Reproductive Medicine, 2019 Heparin-induced thrombocytopenia is a rare and life-threatening condition of exposure to heparin. A case of heparin-induced thrombocytopenia due to the low molecular weight heparin was presented.
Yasin Durmuş +8 more
doaj +1 more source
Case Reports in Hematology, 2020 Heparin-induced thrombocytopenia is a life-threatening complication of exposure to heparin. Heparin-induced thrombocytopenia results from an autoantibody directed against platelet factor 4 in complex with heparin.
Mohamed Aon, Omar Al-Shammari
doaj +1 more source
Design of a new type of coating for the controlled release of heparin [PDF]
, 1997 Thrombus formation at the surface of blood contacting devices can be prevented by local release of heparin. Preferably, the release rate should be constant for prolonged periods of time.
Engbers, G.H.M. +4 more
core +3 more sources
Single-molecule force spectroscopy reveals structural differences of heparan sulfate chains during binding to vitronectin [PDF]
Phys. Rev. E 104, 024409 (2021), 2021 The syndecans represent an ongoing research field focused on their regulatory roles in normal and pathological conditions. Syndecan's role in cancer progression becomes well-documented, implicating their importance in diagnosis and even proposing various cancer potential treatments.
arxiv +1 more source
Heparin modification of a biomimetic bone matrix modulates osteogenic and angiogenic cell response in vitro [PDF]
European Cells & Materials, 2017 In this study, the effect of heparin-modified collagen type I/hydroxyapatite (HA) nanocomposites on key processes of bone regeneration – osteogenesis and angiogenesis – was characterised in vitro.
M Quade +9 more
doaj +1 more source
Our experience of coronary angiography with and without heparin
Indian Heart Journal, 2012 Aim: Coronary angiography is usually done with heparin. Our aim is to see whether it can be done without heparin through femoral route and its effect on local complications.
Goutam Datta +5 more
doaj +1 more source